Log in to search using one of your social media accounts:

 

Kaleo launches program to get Auvi-Q allergy auto-injector into schools

Kaleo said today that it launched a new program to offer its epinephrine auto-injector, Auvi-Q, free-of-charge to all public elementary schools in the U.S. The program is slated to give up to four Auvi-Q cartons per school each academic year. Each carton has two auto-injectors and a training device. Get the full story at our sister site, Drug Delivery Business News. The post Kaleo launches program to get Auvi-Q allergy auto-injector into schools appeared first on MassDevice.
Source: Mass Device - Category: Medical Devices Authors: Tags: Drug-Device Combinations Pharmaceuticals Respiratory Kaleo Inc Source Type: news

Related Links:

Almost three - fourths of survey respondents report having used a colleague's password to access EMRs
Source: The Doctors Lounge - Psychiatry - Category: Psychiatry Tags: Cardiology, Dermatology, Endocrinology, Family Medicine, Geriatrics, Gastroenterology, Gynecology, Infections, AIDS, Internal Medicine, Allergy, Critical Care, Emergency Medicine, Nephrology, Neurology, Nursing, Oncology, Ophthalmology, Orthopedics, ENT, Source Type: news
The FDA recently released draft guidance offering recommendations for holders of biologics license applications (BLAs) on the minor changes that should be documented in an annual report. As the number of chemistry, manufacturing and controls (CMC) postapproval manufacture supplements continue to increase, the FDA decided to publish this guidance. Guidance This guidance provides recommendations to holders of biologics license applications (BLAs) for specified products regarding the types of changes to an approved BLA to be documented in an annual report under 21 CFR 601.12. Specifically, the guidance describes chemistry, ...
Source: Policy and Medicine - Category: American Health Authors: Source Type: blogs
(MedPage Today) -- They also had longer length of stay
Source: MedPage Today Allergy - Category: Allergy & Immunology Source Type: news
Myanmar Wholesale of Maplewood, Minnesota is recalling all packages of Thanlwin brand Fried Bean Snack, because it may contain undeclared peanuts. People who have an allergy or severe sensitivity to peanuts run the risk of serious or life-threatening allergic reaction if they consume these products. Thanlwin Fried Bean Snack was distributed nationwide thru ethnic retail grocery stores.
Source: Food and Drug Administration - Category: Food Science Source Type: news
The challenge of explaining updated guidelines on the introduction of peanut products will be among the topics addressed at the American College of Allergy, Asthma&Immunology (ACAAI) meeting.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Allergy & Clinical Immunology News Source Type: news
About half of increase due to educational attainment, rising demand, liberalizing gender attitudes
Source: Pulmonary Medicine News - Doctors Lounge - Category: Respiratory Medicine Tags: Cardiology, Dermatology, Endocrinology, Family Medicine, Geriatrics, Gastroenterology, Gynecology, Infections, AIDS, Internal Medicine, Allergy, Critical Care, Emergency Medicine, Nephrology, Neurology, Nursing, Oncology, Ophthalmology, Orthopedics, ENT, Source Type: news
Conditions:   Influenza;   Hepatitis A;   Typhoid;   Healthy Adults Interventions:   Biological: Fluzone® quadrivalent;   Biological: Fluzone High Dose;   Biological: Fluad;   Biological: Vaqta;   Biological: Typhim Vi;   Biological: Vivotif Sponsors:   Stanford University;   National Institute of Allergy and Infectious Diseases (NIAID) Enrolling by invitation
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Researchers at Pitzer College screened 3,715 highly-intelligent people for mental illness. They found they had double the rate of mental illness and a higher risk of asthma and allergies than others.
Source: the Mail online | Health - Category: Consumer Health News Source Type: news
(Reuters) - A U.S. judge ’s ruling on Monday invalidating Allergan Plc's patents on its blockbuster $1.5 billion dry-eye medicine, Restasis, has cast doubt on the company's novel strategy to enlist a Native American tribe to help shield those patents from challenge by generic drugmakers, legal experts said.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news
Organic yogurt maker, Stonyfield, is voluntarily recalling a specific code date of its O ’Soy Strawberry soy yogurt because it may contain an undeclared milk allergen. People who have an allergy or severe sensitivity to milk run the risk of serious or life-threatening allergic reaction if they consume this product.
Source: Food and Drug Administration - Category: Food Science Source Type: news
More News: Academia | Allergy | Allergy & Immunology | Respiratory Medicine | Training | Universities & Medical Training